European Journal of Chemistry

iNOS inhibitors: Benzimidazole-coumarin derivatives to combat inflammation

Crossmark


Main Article Content

Richa Minhas
Yogita Bansal

Abstract

Inducible nitric oxide synthase (iNOS) plays an important role in the inflammatory processes via accelerating the production of nitric oxide (NO). The efforts to develop small molecules as selective inhibitors of iNOS are being reported across the globe. The current study explores varied benzimidazole-coumarin derivatives as anti-iNOS agents. Literature survey suggests 2-aminobenzimidazole, coumarin nucleus, and 4-atom linker as important structural components for iNOS inhibition. Target compounds were designed and synthesized by coupling 2-aminobenzimidazole with (un)substituted coumarin through different linkers. These were docked in iNOS (1QW4) and nNOS (1QW6) targets to ascertain their iNOS selectivity, and evaluated for NO and iNOS inhibitory activities in vitro. The most active inhibitors were subsequently evaluated for acute toxicity and anti-inflammatory activity using carrageenan-induced rat paw edema model in vivo. All compounds possessed moderate to good NO and iNOS inhibitory activities. Compounds 14a, 14b, 14d, and 14e were the most potent inhibitors in vitro. These were found to significantly reduce the inflammation. Compounds 14d and 14e have been identified as the most potent iNOS inhibitors to combat inflammation. These derivatives may serve as potential compounds as such against iNOS, or as leads for the development of novel anti-iNOS agents.


icon graph This Abstract was viewed 511 times | icon graph Article PDF downloaded 291 times

How to Cite
(1)
Minhas, R.; Bansal, Y. INOS Inhibitors: Benzimidazole-Coumarin Derivatives to Combat Inflammation. Eur. J. Chem. 2022, 13, 307-318.

Article Details

Share
Crossref - Scopus - Google - European PMC
References

[1]. Kahlenberg, J. M.; Fox, D. A. Advances in the medical treatment of rheumatoid arthritis. Hand Clin. 2011, 27, 11-20.
https://doi.org/10.1016/j.hcl.2010.09.002

[2]. Handa, R.; Rao, U. R. K.; Lewis, J. F. M.; Rambhad, G.; Shiff, S.; Ghia, C. J. Literature review of rheumatoid arthritis in India. Int. J. Rheum. Dis. 2016, 19, 440-451.
https://doi.org/10.1111/1756-185X.12621

[3]. Upadhyay, K.; Bavishi, A.; Thakrar, S.; Radadiya, A.; Vala, H.; Parekh, S.; Bhavsar, D.; Savant, M.; Parmar, M.; Adlakha, P.; Shah, A. Synthesis and biological evaluation of 4-styrylcoumarin derivatives as inhibitors of TNF-α and IL-6 with anti-tubercular activity. Bioorg. Med. Chem. Lett. 2011, 21, 2547-2549.
https://doi.org/10.1016/j.bmcl.2011.02.016

[4]. Abdelazeem, A. H.; Khan, S. I.; White, S. W.; Sufka, K. J.; McCurdy, C. R. Design, synthesis and biological evaluation of bivalent benzoxazolone and benzothiazolone ligands as potential anti-inflam-matory/ analgesic agents. Bioorg. Med. Chem. 2015, 23, 3248-3259.
https://doi.org/10.1016/j.bmc.2015.04.057

[5]. Cinelli, M. A.; Do, H. T.; Miley, G. P.; Silverman, R. B. Inducible nitric oxide synthase: Regulation, structure, and inhibition Med. Res. Rev. 2020, 40, 158-189.
https://doi.org/10.1002/med.21599

[6]. Minhas, R.; Bansal, Y.; Bansal, G. Inducible nitric oxide synthase inhibitors: A comprehensive update. Med. Res. Rev. 2020, 40, 823-855.
https://doi.org/10.1002/med.21636

[7]. Kadhum, A. A. H.; Al-Amiery, A. A.; Musa, A. Y.; Mohamad, A. B. The antioxidant activity of new coumarin derivatives. Int. J. Mol. Sci. 2011, 12, 5747-5761.
https://doi.org/10.3390/ijms12095747

[8]. Kostova, I. Synthetic and natural coumarins as antioxidants. Mini Rev. Med. Chem. 2006, 6, 365-374.
https://doi.org/10.2174/138955706776361457

[9]. Minhas, R.; Bansal, Y. Inhibition of iNOS by benzimidazole derivatives: Synthesis, docking, and biological evaluations. Med. Chem. 2022, 18, 602-615.
https://doi.org/10.2174/1573406417666210927123137

[10]. Maestro- Schrödinger Release 2022-2: Maestro, Schrödinger, LLC, New York, NY, 2021.

[11]. Ahluwalia, V. K.; Bhagat, P.; Aggarwal, R.; Chandra, R. Intermediates for organic synthesis; I. K. International Publishing House: New Delhi, India, 2005.

[12]. ChemBioDraw Ultra 12.0. CambridgeSoft, 100 Cambridge Park Drive, Cambridge, MA 02140. www.cambridgesoft.com (accessed June 17, 2022).

[13]. LigPrep - Schrödinger Release 2022-2: LigPrep, Schrödinger, LLC, New York, NY, 2021.

[14]. Kaminski, G. A.; Friesner, R. A.; Tirado-Rives, J.; Jorgensen, W. J. Evaluation and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on Peptides. J. Phys. Chem. B 2001, 105 (28), 6474-6487.
https://doi.org/10.1021/jp003919d

[15]. RCSB Protein Data Bank RCSB PDB: Homepage. https://www.rcsb.org/ (accessed June 17, 2022).

[16]. QikProp - Schrödinger Release 2022-2: QikProp, Schrödinger, LLC, New York, NY, 2021.

[17]. Mishra, T.; Bhatia, A. Augmentation of expression of immunocytes' functions by seed extract of Ziziphusmauritiana (Lamk.). J. Ethnopharmacol. 2010, 127, 341-345.
https://doi.org/10.1016/j.jep.2009.10.033

[18]. Minhas, R.; Bansal, G.; Bansal, Y. Novel coupled molecules from active structural motifs of synthetic and natural origin as immunosuppressants. Med. Chem. 2020, 16, 544-554.
https://doi.org/10.2174/1573406415666190409111459

[19]. OECD guidelines for the testing of chemicals - section 4: Health effects: Test no. 425: Acute oral toxicity: Up-and-down procedure; Organisation for Economic Co-Operation and Development, 2014.

[20]. Salvemini, D.; Wang, Z.-Q.; Wyatt, P. S.; Bourdon, D. M.; Marino, M. H.; Manning, P. T.; Currie, M. G. Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation. Br. J. Pharmacol. 1996, 118, 829-838.
https://doi.org/10.1111/j.1476-5381.1996.tb15475.x

[21]. GraphPad Prism version 8.0.0 for Windows, GraphPad Software, San Diego, California USA, www.graphpad.com. (accessed June 17, 2022).

[22]. Jackson, S. A.; Sahni, S.; Lee, L.; Luo, Y.; Nieduzak, T. R.; Liang, G.; Chiang, Y.; Collar, N.; Fink, D.; He, W.; Laoui, A.; Merrill, J.; Boffey, R.; Crackett, P.; Rees, B.; Wong, M.; Guilloteau, J.-P.; Mathieu, M.; Rebello, S. S. Design, synthesis and characterization of a novel class of coumarin-based inhibitors of inducible nitric oxide synthase. Bioorg. Med. Chem. 2005, 13, 2723-2739.
https://doi.org/10.1016/j.bmc.2005.02.036

[23]. Singh, M.; Silakari, O. Design, synthesis and biological evaluation of novel 2-phenyl-1-benzopyran-4-one derivatives as potential poly-functional anti-Alzheimer's agents. RSC Adv. 2016, 6, 108411-108422.
https://doi.org/10.1039/C6RA17678J

[24]. Silverstein, R. M.; Webster, F. X.; Kiemle, D. J. The spectrometric identification of organic compounds; 7th ed.; John Wiley & Sons: Nashville, TN, 2005.

[25]. Carrión, M. D.; López Cara, L. C.; Camacho, M. E.; Tapias, V.; Escames, G.; Acuña-Castroviejo, D.; Espinosa, A.; Gallo, M. A.; Entrena, A. Pyrazoles and pyrazolines as neural and inducible nitric oxide synthase (nNOS and iNOS) potential inhibitors (III). Eur. J. Med. Chem. 2008, 43, 2579-2591.
https://doi.org/10.1016/j.ejmech.2008.01.014

[26]. Annunziata, F.; Pinna, C.; Dallavalle, S.; Tamborini, L.; Pinto, A. An overview of coumarin as a versatile and readily accessible scaffold with broad-ranging biological activities. Int. J. Mol. Sci. 2020, 21, 4618.
https://doi.org/10.3390/ijms21134618

Most read articles by the same author(s)
TrendMD

Dimensions - Altmetric - scite_ - PlumX

Downloads and views

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...
License Terms

License Terms

by-nc

Copyright © 2024 by Authors. This work is published and licensed by Atlanta Publishing House LLC, Atlanta, GA, USA. The full terms of this license are available at https://www.eurjchem.com/index.php/eurjchem/terms and incorporate the Creative Commons Attribution-Non Commercial (CC BY NC) (International, v4.0) License (http://creativecommons.org/licenses/by-nc/4.0). By accessing the work, you hereby accept the Terms. This is an open access article distributed under the terms and conditions of the CC BY NC License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited without any further permission from Atlanta Publishing House LLC (European Journal of Chemistry). No use, distribution, or reproduction is permitted which does not comply with these terms. Permissions for commercial use of this work beyond the scope of the License (https://www.eurjchem.com/index.php/eurjchem/terms) are administered by Atlanta Publishing House LLC (European Journal of Chemistry).